Conba Buys 84% of Yunnan Xiogye Pharma

December 7, 2011 -- Zhejiang Conba Pharma bought an 84% stake in Yunnan Xiongye Pharmaceutical Ltd., a company that makes both TCMs and western drugs. Last year, Xiongye lost $739,000 on $1.2 million of revenue. Founded in 1969, Xiongye has a portfolio of over 40 products, the ostensible reason for Conba’s interest. Terms of the transaction were not disclosed. More details.

Stock Symbol: (SHA: 600572)

MORE ON THIS TOPIC